IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production
Bradda Head Lithium exceeds targets, secures US$3 million royalty and moves closer to productionView Video
IntelliAM aiming for significant growth with £5 million Aquis IPO
IntelliAM aiming for significant growth with £5 million Aquis IPOView Video

Latest Share Chat

Wednesday broker round-up

Wed, 14th Apr 2021 13:07

(Sharecast News) - Gamesys Group: Canaccord downgrades to hold with a target price of 1,878p.



Watkin Jones: Berenberg reiterates buy with a target price of 280p.

Boohoo Group: Berenberg reiterates buy with a target price of 460p.

Quixant: Canaccord reiterates buy with a target price of 200p.

Babcock: JP Morgan upgrades to overweight with a target price of 350p.

Restaurant Group: JP Morgan downgrades to neutral with a target price of 120p.

Just Eat: Barclays reiterates overweight with a target price of 121p.

IQE: Deutsche Bank reiterates buy with a target price of 80p.

AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p.

XP Power: Liberum reiterates buy with a target price of 6,500p.

British Land: Liberum reiterates hold with a target price of 500p.

Qinetiq: Numis reiterates buy with a target price of 400p.

Related Shares

More News
2 Jul 2024 09:47

LONDON BROKER RATINGS: Deutsche Bank cuts Quilter, ups Polar Capital

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

1 Jul 2024 09:13

TOP NEWS: AstraZeneca cancer and Covid drugs recommended for approval

(Alliance News) - AstraZeneca PLC on Monday said two cancer treatments had been recommended for approval in the European Union, while there was also p...

1 Jul 2024 07:41

LONDON BRIEFING: Stocks called higher ahead of Thursday's election

(Alliance News) - Stocks in London are called to open higher on Monday, at the start of a politically fuelled week.

1 Jul 2024 07:17

AstraZeneca endometrial cancer treatment recommended for EU approval

(Sharecast News) - AstraZeneca announced on Monday that 'Imfinzi', or durvalumab, and 'Lynparza', or olaparib, have received a recommendation for appr...

27 Jun 2024 13:00

German vaccine panel endorses Astra-Sanofi's RSV shot for infants

FRANKFURT, June 27 (Reuters) - Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca a...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.